Evidence map›Paper›PMID 39356605›Full record

ArticleIEEE journal of biomedical and health informatics2025

Longitudinal Alzheimer's Disease Progression Prediction With Modality Uncertainty and Optimization of Information Flow.

Duy-Phuong Dao, Hyung-Jeong Yang, Jahae Kim, Ngoc-Huynh Ho

Abstract read
In one paragraph

Article in IEEE journal of biomedical and health informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Duy-Phuong Dao
Hyung-Jeong Yang
Jahae Kim
Ngoc-Huynh Ho

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MONICA G. RIVERA-MINDT · 2016 to 2026
$226.7M
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Korea Government (MSIT)National Research Foundation of KoreaNIA NIH HHS U01 AG024904NIA NIH HHS U19 AG024904
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a global neurodegenerative disorder that affects millions of individuals worldwide. Actual AD imaging datasets challenge the construction of reliable longitudinal models owing to imaging modality uncertainty. In addition, they are still unable to retain or obtain important information during disease progression from previous to followup time points. For example, the output values of current gates in recurrent models should be close to a specific value that indicates the model is uncertain about retaining or forgetting information. In this study, we propose a model which can extract and constrain each modality into a common representation space to capture intermodality interactions among different modalities associated with modality uncertainty to predict AD progression. In addition, we provide an auxiliary function to enhance the ability of recurrent gate robustly and effectively in controlling the flow of information over time using longitudinal data. We conducted comparative analysis on data from the Alzheimer's Disease Neuroimaging Initiative database. Our model outperformed other methods across all evaluation metrics. Therefore, the proposed model provides a promising solution for addressing modality uncertainty challenges in multimodal longitudinal AD progression prediction.

Indexed as

Alzheimer DiseaseImage Interpretation, Computer-AssistedNeuroimagingAgedAlgorithmsBrainDatabases, FactualDisease ProgressionHumansLongitudinal StudiesUncertainty

Identifiers

PMID39356605
PMCPMC11875883

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.